HOME >> BIOLOGY >> NEWS
University of Cincinnati receives $1.7M to research molecular treatment of brain injury

CINCINNATIThe National Institutes of Health has awarded $1.7 million to a University of Cincinnati (UC) scientist to do molecular research that could lead to better treatments for brain injury patients.

Kenneth Strauss, PhD, will study two types of molecules known as eicosanoids (eye-KO-sa-noids), which are created by injured brain cells, to confirm that they can actually protect healthy brain cells from further damage.

If successful, Strausss research could lead to a new class of drugs designed to enhance the levels of these helpful molecules, and thereby improve outcomes in patients who have suffered traumatic brain injury, the leading cause of death and disability among people aged 16 to 45.

One of my goals, says Strauss, a research associate professor of neurosurgery at UC and director of the Mayfield Neurotrauma Research Lab, is to develop therapies for traumatic brain injury, a condition for which there is no effective medical treatment.

When the brain suffers traumatic injury, Strauss explains, it automatically takes self-protective action. The brain cells release arachidonic acid, which triggers a series of events that draw additional cells to the injured site.

While some of the compounds resulting from the initial trauma appear to be protective and to inhibit harmful inflammation, Strauss says, others are harmful if they remain for too long. Their fight to save the injured brain can spill over into nearby areas, damaging neighboring structures.

Brain cells and immune system cells in the blood stream alter their function and essentially gather at the damage site, Strauss says. They can proliferate and release chemicals that cause the region to swell up. In their effort to either cordon off or repair the damage, they can also constrict blood vessels or attract even more cells into that area.

Thus far doctors have been unable to prevent or manipulate these progressive changes that foll
'"/>

Contact: Cindy Starr
cstarr@mayfieldclinic.com
513-569-5321
University of Cincinnati
5-Jul-2007


Page: 1 2

Related biology news :

1. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
2. A study by the MUHC and McGill University opens a new door to understanding cancer
3. Biologists at Tufts University discover 1 reason why chromosomes break, often leading to cancer
4. $9M grant awarded to University of Cincinnati for bipolar disorder research
5. University of Leeds strengthens China links in membrane and neurobiology
6. University of Colorado licenses two influenza virus detection discoveries to Quidel Corp.
7. Manchester University helps with pharaoh DNA analysis
8. University of Arizona launches major scientific research initiative at Biosphere 2
9. Link between obesity and enlarged heart discovered by University of Arizona researchers
10. Bee researcher at Arizona State University is 1 of 20 new Pew Scholars in the biomedical sciences
11. University of Pittsburgh School of Medicine researchers develop off-the-shelf vascular grafts

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/18/2018)... ... December 18, 2018 , ... ... cancers and other serious diseases, today announced the publication of an early feasibility ... treatment of rGBM. , The publication of the study, An Early Feasibility ...
(Date:12/14/2018)... ... 2018 , ... uBiome, the leader in microbial genomics, announced ... and Therapeutics” by the US Patent and Trademark Office on July 11, 2017 ... by uBiome collaborators Dr. Zachary Apte, Dr. Daniel Almonacid, Dr. Jessica Richman, and ...
(Date:12/13/2018)... ... December 12, 2018 , ... NDA Partners Chief Executive ... prominent Expert Consultants, was recently honored by the American Association of Pharmaceutical Scientists ... in pharmaceutical science, technology, engineering, or education and whose contributions to the pharmaceutical ...
Breaking Biology News(10 mins):
(Date:1/8/2019)... ... ... The American Society of Gene and Cell Therapy’s (ASGCT) first class ... of industry leaders identified by the ASGCT board of directors. In total, the Society ... ASGCT members designing transformative pilot studies in gene and cell therapy as they prepare ...
(Date:1/4/2019)... ... January 03, 2019 , ... ... oncolytic virus-based immunotherapies for cancer, today announced the founding of a scientific and ... input and guidance from key leaders in the Immuno-Oncology field. The founding members ...
(Date:12/18/2018)... ... December 18, 2018 , ... USDM Life Sciences, ... life sciences industry, unveiled a completely redesigned website at http://www.usdm.com . The ... experience for their valued clients and business partners. , The website has ...
(Date:12/13/2018)... YORK (PRWEB) , ... December 12, 2018 , ... Helping ... Styletto- their new sleek and slim hearing aid within its Vision and Hearing campaign ... hearing loss. , Studies show that despite continued efforts to destigmatize hearing aids ...
Breaking Biology Technology:
Cached News: